Harte-Hanks (NASDAQ: HHS) reported Q4 EPS of ($0.27), $0.39 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $49.49 million versus the consensus estimate of $47 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.